Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population. A post-hoc ...

In 2025, the number of all students enrolled in medical school reached 100,723 — a significant milestone for the future of ...

After controlling for known CV risk factors, all FFR-CT subgroups remained significantly associated with MI, ...

Tirzepatide noninferior to dulaglutide with respect to composite of death from cardiovascular causes, myocardial infarction, ...

The number and frequency of intravesical instillations for non-muscle-invasive bladder cancer (NMIBC) impairs quality of life and needs to be reported in clinical trials.

Atacicept, a novel dual inhibitor of BAFF and APRIL, receives FDA Priority Review for IgA nephropathy treatment in adults.

When cancer subtypes were examined, the analysis revealed that phototherapy was linked to a 40% increased odds of blood cancers. More modest associations were observed for solid organ cancers and ...

Beyond broad recommendations for recurrent kidney stone prevention, clinicians and renal dietitians can create personalized plans.

Researchers reported on patient acceptance of an e-consent tool for asynchronous delivery of study information and for receiving consent from patients.

(HealthDay News) — Chronic kidney disease (CKD) reduces quality of life (QoL) for patients and their caregivers globally, according to a study published online Dec. 24 in Advances in Therapy.

SunRISe-4 evaluated neoadjuvant gemcitabine intravesical system (TAR-200) plus cetrelimab or cetrelimab monotherapy for pathologic complete response in patients with MIBC ineligible for or refusing ...

The FDA may allow warning labels to appear just once per package rather than after every health claim. (HealthDay News) — The U.S. Food and Drug Administration (FDA) is weighing a change that could ...